Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Peripheral Vascular Devices Pipeline Market Report Overview

Peripheral vascular devices are used to treat peripheral vascular disease (PVD). The Peripheral Vascular Devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Peripheral Vascular Stents

·        PTA Peripheral DCB Catheters

·        PTA Balloon Catheters

·        Peripheral Embolic Protection Devices

·        Arteriotomy Closure Device

·        Others

Key Territories ·        The US

·        China

·        Europe

·        Japan

·        Australia

Key Regulatory Paths ·        NMPA

·        PMA

·        CE

·        510(k)

·        Shonin

Leading Companies ·        3D Biotek LLC

·        Abbott Vascular Inc.

·        Ablative Solutions Inc.

·        Acotec Scientific Co Ltd

·        Adept Medical Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Peripheral Vascular Devices Pipeline Market by Segments

A few of the key segments in the peripheral vascular devices pipeline market are peripheral vascular stents, PTA peripheral DCB catheters, PTA balloon catheters, peripheral embolic protection devices, and arteriotomy closure devices, among others. As of December 2023, peripheral vascular stents accounted for the highest number of pipeline products.

A peripheral vascular stent is an expandable perforated tube that is inserted into a peripheral vessel to prevent blood flow constriction. It can be further sub-segmented into bare metal stents (BMS), drug eluting stents (DES), covered stents, and bio-absorbable stents.

Peripheral Vascular Devices Pipeline Market Analysis by Segments, 2023 (%)

Peripheral Vascular Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Peripheral Vascular Devices Pipeline Market

Download a Free Report Sample

Peripheral Vascular Devices Pipeline Market Segmentation by Territories

A few of the key territories for peripheral vascular devices pipeline products are the US, China, Europe, Japan, and Australia. As of December 2023, the US accounted for the highest number of pipeline products.

Peripheral Vascular Devices Pipeline Market Analysis by Territories, 2023 (%)

Peripheral Vascular Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Peripheral Vascular Devices Pipeline Market

Download a Free Report Sample

Peripheral Vascular Devices Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the peripheral vascular devices pipeline market are NMPA, PMA, CE, 510(k), and Shonin. As of December 2023, NMPA was the most followed pathway for pipeline products in the market.

Peripheral Vascular Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Peripheral Vascular Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Peripheral Vascular Devices Pipeline Market

Download a Free Report Sample

Peripheral Vascular Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the peripheral vascular devices pipeline market are 3D Biotek LLC, Abbott Vascular Inc., Ablative Solutions Inc., Acotec Scientific Co Ltd, and Adept Medical Ltd, among others.

Abbott Vascular Inc: Abbott Vascular is headquartered in Santa Clara, California, the US. It is a medical device company that develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It offers education and training services for healthcare professionals.

Adept Medical Ltd: Adept Medical is headquartered in Auckland, New Zealand. It is a medical device company that manufactures and distributes medical plastics and composites. It offers surgical and ENT products. Its products include otological ventilation tubes, otological instruments, and otological kits, among others. Adept Medical’s otological ventilation tubes are used in the treatment of otitis media.

Peripheral Vascular Devices Pipeline Market Analysis by Companies, 2023

Peripheral Vascular Devices Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Peripheral Vascular Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Peripheral Vascular Devices Pipeline Market Segments Outlook

  • Peripheral Vascular Stents
  • PTA Peripheral DCB Catheters
  • PTA Balloon Catheters
  • Peripheral Embolic Protection Devices
  • Arteriotomy Closure Device
  • Radiofrequency Catheters
  • Renal Denervation Catheters
  • Peripheral Guidewires
  • Bioabsorbable Stents (BAS)
  • Drug Eluting Stents (DES)
  • Active Closure Devices
  • Carotid Artery Bare Metal Stents
  • Carotid Embolic Protection Devices
  • Venous Stents
  • Ultrasound Catheters
  • Iliac Artery Stents
  • Detachable Vascular Embolization Coils
  • Vascular Embolization Plugs
  • Tracheobronchial Stent
  • Carotid and Renal Artery Stents
  • Bare Metal Stents (BMS)
  • Renal Artery Bare Metal Stents
  • Lower Extremity Embolic Protection Devices
  • Passive Closure Devices
  • Peripheral Vascular Retrieval Devices
  • Hydrophilic Peripheral Guidewires
  • Standard Balloon Catheters
  • Vascular Embolization Plugs and Coils
  • Vascular Embolization Coils

Peripheral Vascular Devices Pipeline Market Territories Outlook

  • The US
  • China
  • Europe
  • Japan
  • Australia

Peripheral Vascular Devices Pipeline Market Regulatory Paths Outlook

  • NMPA
  • PMA
  • CE
  • 510(k)
  • Shonin

Scope

This report provides:

  • Extensive coverage of the Peripheral Vascular Devices under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Peripheral Vascular devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development, ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Peripheral Vascular devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

3D Biotek LLC
Abbott Vascular Inc
Ablative Solutions Inc
Acotec Scientific Co Ltd
Acotec Scientific Holdings Ltd
Adept Medical Ltd
Agile Devices Inc
Allegra Orthopaedics Ltd
Alucent Biomedical Inc
Alucent Biomedical Inc
amg International GmbH
Amplitude Vascular Systems Inc
Andramed GmbH
AndraTec GmbH
AnGes Inc
AngioCure, Inc.
AngioDynamics Inc
AorticLab Sarl
Aporo Biomedical, Inc. (Inactive)
APT Medical Inc
Arterius Ltd
Artio Medical
Artventive Medical Group Inc
Ascenion GmbH
Atrium Medical Corp
Avalon Laboratories LLC
Avantec Vascular Corp
Becton Dickinson and Co
Ben-Gurion University of the Negev
Biotronik AG
Biotyx Medical (Shenzhen) Co Ltd
Boston Scientific Corp
Boston Scientific Scimed Inc
Boston TransTec LLC
Brattea
CardioDex Ltd (Inactive)
Cardio-Flow Ltd.
Cardionovum GmbH
Cardiovascular Systems Inc
Cardiva Medical Inc
Catharos Medical Systems Inc
CaveoMed GmbH
Chansu Vascular Technologies LLC
Clemson University
CloSys Corp
Concept Medical Inc
Contego Medical LLC
Cook Medical Inc
Cordis Corp
CorInnova, Inc.
Covidien Ltd
CPC of America Inc
CR Bard Inc
CryoMedix, LLC.
CyndRX LLC
Cytograft Tissue Engineering Inc (Inactive)
Deep Vein Medical, Inc.
Dextera Surgical Inc
Dingke Medical Technology (Suzhou) Co Ltd
Dongguan TT Medical Inc
Dublin City University
Echopoint Medical Ltd
Edwards Lifesciences Corp
Efemoral Medical LLC
Efferent Labs Inc
Electroformed Stents Inc
Elixir Medical Corp
Emboline, Inc.
Endocor GmbH
Endomimetics LLC
EndoPhlebex Technologies, Inc
enVVeno Medical Corp
EpiEP, Inc.
Eqalix, Inc.
eucatech AG
Ev3 Inc
Evasc Medical Systems Corp
Eximo Medical Ltd
Filterlex Medical Ltd
FIT Biotech Oy (Inactive)
Flomatrix Pty Ltd
FlowCo Inc.
Fluidx Medical Technology LLC
Genesis MedTech International Pvt Ltd
George Washington University
Gradient Denervation Technologies
Guerbet SA
Hadassah Medical Center
Handok-Kalos Medical
Hansen Medical Inc (Inactive)
Harvard University
HeMo Bioengineering Ltd
Hexacath SA
ID Nest Medical SAS
Inari Medical Inc
InnoRa GmbH
Innova Vascular Inc
Innovative Cardiovascular Solutions, LLC
Innovein Medical Inc
Innovia LLC
InspireMD Inc
Instylla Inc
International Cardio Corp
InterVene Inc.
Intressa Vascular SA
InVera Medical Ltd
IPI Singapore
Javelin Medical Ltd
Johns Hopkins University
Keystone Heart Ltd
Kona Medical Inc
Kyoto Medical Planning Co Ltd
LeMaitre Vascular Inc
LeoMed, LLC
Lepu Medical Technology (Beijing) Co Ltd
Lepu Scientech Medical Technology (Shanghai) Co Ltd
Lifetech Scientific (Shenzhen) Co Ltd
LimFlow SA
LuSeed Vascular
Lutonix Inc
Lyra Therapeutics Inc
Marblehead Medical LLC
Mayo Clinic
Medical Device Creations Ltd.
Medikit Co Ltd
Medtronic Plc
Mercator MedSystems Inc
Meril Life Sciences Pvt Ltd
Micell Technologies Inc
Micro Medical Solutions Inc
MicroPort CardioFlow Medtech Corp
MicroPort Scientific Corp
MIV Therapeutics Inc
Nanjing SealMed Medical Technology Corp Ltd
Nanjing Xinke Medical Devices Co Ltd
Natec Medical Ltd
Navi Medical Technologies Pty Ltd
Navis Medical
Neovasc Inc
Nesstent Ltd.
Neurosonix Ltd.
NewMed Medical Co Ltd
NIH Office of Technology Transfer
Nipro Corp
Northwestern University
Northwind Medical Inc
NovaPulse Ltd
Novoheart Holdings Inc
NSVascular, Inc.
NuVascular Technologies Inc
OrbusNeich
Orchestra BioMed Inc
Oregon Health & Science University
Palmaz Scientific Inc (Inactive)
PerAssist Ltd
PeriTec Biosciences Ltd
Perseus Biomed Ltd
PQ Bypass Inc
Praxis Medical Devices Ltd
ProMed Inc
Protembis GmbH
Pulsus Medical LLC (Inactive)
QT Vascular Ltd
QualiMed Innovative Medizinprodukte GmbH
Qvanteq AG
R3 Vascular Inc
RadSense
Reflow Medical, Inc.
RegenMedTX LLC
Renal Dynamics, LLC
Renaly Ltd
Reprieve Cardiovascular Inc
REVA Medical Inc
Rex Medical LP
Rontis AG
Rutgers The State University of New Jersey
Shanghai AngioCare Medical Technology Co Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Changde Medical Technology Co Ltd
Shanghai Golden Leaf Medtech Co Ltd
Shanghai Healing Medical Instruments Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Shanghai Shenqi Medical Technology Co Ltd
Shanghai Xuanyu Medical Equipment Co Ltd
Shape Memory Medical Inc
Shenzhen Salubris Pharmaceuticals Co Ltd
Shockwave Medical Inc
SiL Vascular Ltd
SoniVie Ltd.
SonoVascular Inc
Sound Interventions, Inc.
SoundBite Medical Solutions Inc
Spectranetics Corp
SpectroCon LLC
Spectrumedics Medical Technology (Shanghai) Co Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stanford University
Stemplant LLC
Straub Medical AG
SurModics Inc
Suzhou Rainmed Medical Technology Co Ltd
Suzhou Xinmai Medical Equipment Co Ltd
Suzhou Yinluo Medical Devices Co Ltd
Suzhou Zhonghui Medical Technology Co Ltd
Symple Surgical Inc
Synergy Flow Ltd
Tailored Medical Devices Inc
Tel Aviv University
Teleflex Inc
Tepha Inc
Terumo Corp
Terumo Interventional Systems
Thrombx Medical Inc
TissueGen Inc
Tractivus SL
Transit Scientific LLC
TransMed7 LLC
Trinity College Dublin
TripleMed BV
Ts3 Medical, Inc.
University of Colorado
University of Illinois at Chicago
University of Louisville
University of Michigan
University of Minnesota
University of Montana
University of Nebraska
University of New Mexico
University of Pittsburgh
University of Pittsburgh Medical Center
University of Rochester
University of Sydney
University of Texas Health Science Center at San Antonio
University of Wisconsin Madison
Vanderbilt University
Vascoscope BV
Vasc-Point Ltd
Vascular Bioresorbable Technologies
Vascular Closure Systems Inc
Vascular Concepts Ltd
Vascular Dynamics Ltd.
Vascular Graft Solutions Ltd
Vascular Nanotransfer Technologies
VeinAid, LLC
Venarum Medical LLC
Venous Stent BV
Venus Medtech Hangzhou Inc
Verigraft AB
Verve Medical, Inc.
Veryan Medical Ltd
Vesper Medical Inc
Vinnova
Vivasure Medical Ltd.
VueKlar Cardiovascular Ltd (Inactive)
W. L. Gore & Associates Inc
Wake Forest University Health Sciences
Weill Cornell Medical College
Xenogenics Corporation
Zhejiang Kindly Medical Devices Co Ltd
Zhuhai Tonbridge Medical Tech Co Ltd
Zorion Medical
Zylox-Tonbridge Medical Technology Co Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 20

|1.2 List of Figures 48

2 Introduction 49

2.1 Peripheral Vascular Devices Overview 49

3 Products under Development 52

3.1 Peripheral Vascular Devices – Pipeline Products by Stage of Development 52

3.2 Peripheral Vascular Devices – Pipeline Products by Segment 53

3.3 Peripheral Vascular Devices – Pipeline Products by Territory 55

3.4 Peripheral Vascular Devices – Pipeline Products by Regulatory Path 57

3.5 Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date 58

3.6 Peripheral Vascular Devices – Ongoing Clinical Trials 59

4 Peripheral Vascular Devices – Pipeline Products under Development by Companies 60

4.1 Peripheral Vascular Devices Companies – Pipeline Products by Stage of Development 60

4.2 Peripheral Vascular Devices – Pipeline Products by Stage of Development 70

5 Peripheral Vascular Devices Companies and Product Overview 81

5.1 3D Biotek LLC Company Overview 81

5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.2 Abbott Vascular Inc Company Overview 82

5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.3 Ablative Solutions Inc Company Overview 88

5.3.1 Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.4 Acotec Scientific Co Ltd Company Overview 91

5.4.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.5 Acotec Scientific Holdings Ltd Company Overview 97

5.5.1 Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

5.6 Adept Medical Ltd Company Overview 104

5.6.1 Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

5.7 Agile Devices Inc Company Overview 105

5.7.1 Agile Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.8 Allegra Orthopaedics Ltd Company Overview 106

5.8.1 Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 106

5.9 Alucent Biomedical Inc Company Overview 107

5.9.1 Alucent Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.10 Alucent Biomedical Inc Company Overview 108

5.10.1 Alucent Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.11 amg International GmbH Company Overview 112

5.11.1 amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 112

5.12 Amplitude Vascular Systems Inc Company Overview 113

5.12.1 Amplitude Vascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.13 Andramed GmbH Company Overview 117

5.13.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 117

5.14 AndraTec GmbH Company Overview 119

5.14.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 119

5.15 AnGes Inc Company Overview 120

5.15.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.16 AngioCure, Inc. Company Overview 121

5.16.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121

5.17 AngioDynamics Inc Company Overview 122

5.17.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.18 AorticLab Sarl Company Overview 124

5.18.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview 124

5.19 Aporo Biomedical, Inc. (Inactive) Company Overview 127

5.19.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 127

5.20 APT Medical Inc Company Overview 128

5.20.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.21 Arterius Ltd Company Overview 134

5.21.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

5.22 Artio Medical Company Overview 135

5.22.1 Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 135

5.23 Artventive Medical Group Inc Company Overview 138

5.23.1 Artventive Medical Group Inc Pipeline Products & Ongoing Clinical Trials Overview 138

5.24 Ascenion GmbH Company Overview 142

5.24.1 Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview 142

5.25 Atrium Medical Corp Company Overview 143

5.25.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 143

5.26 Avalon Laboratories LLC Company Overview 144

5.26.1 Avalon Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview 144

5.27 Avantec Vascular Corp Company Overview 145

5.27.1 Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 145

5.28 Becton Dickinson and Co Company Overview 146

5.28.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 146

5.29 Ben-Gurion University of the Negev Company Overview 151

5.29.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 151

5.30 Biotronik AG Company Overview 152

5.30.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 152

5.31 Biotyx Medical (Shenzhen) Co Ltd Company Overview 153

5.31.1 Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 153

5.32 Boston Scientific Corp Company Overview 156

5.32.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 156

5.33 Boston Scientific Scimed Inc Company Overview 169

5.33.1 Boston Scientific Scimed Inc Pipeline Products & Ongoing Clinical Trials Overview 169

5.34 Boston TransTec LLC Company Overview 170

5.34.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 170

5.35 Brattea Company Overview 171

5.35.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview 171

5.36 CardioDex Ltd (Inactive) Company Overview 172

5.36.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 172

5.37 Cardio-Flow Ltd. Company Overview 173

5.37.1 Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 173

5.38 Cardionovum GmbH Company Overview 174

5.38.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 174

5.39 Cardiovascular Systems Inc Company Overview 175

5.39.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 175

5.40 Cardiva Medical Inc Company Overview 179

5.40.1 Cardiva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 179

5.41 Catharos Medical Systems Inc Company Overview 182

5.41.1 Catharos Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 182

5.42 CaveoMed GmbH Company Overview 183

5.42.1 CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 183

5.43 Chansu Vascular Technologies LLC Company Overview 185

5.43.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 185

5.44 Clemson University Company Overview 188

5.44.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 188

5.45 CloSys Corp Company Overview 189

5.45.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 189

5.46 Concept Medical Inc Company Overview 190

5.46.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 190

5.47 Contego Medical LLC Company Overview 195

5.47.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 195

5.48 Cook Medical Inc Company Overview 200

5.48.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 200

5.49 Cordis Corp Company Overview 204

5.49.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 204

5.50 CorInnova, Inc. Company Overview 213

5.50.1 CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 213

5.51 Covidien Ltd Company Overview 214

5.51.1 Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 214

5.52 CPC of America Inc Company Overview 215

5.52.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 215

5.53 CR Bard Inc Company Overview 216

5.53.1 CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 216

5.54 CryoMedix, LLC. Company Overview 217

5.54.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview 217

5.55 CyndRX LLC Company Overview 218

5.55.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview 218

5.56 Cytograft Tissue Engineering Inc (Inactive) Company Overview 219

5.56.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 219

5.57 Deep Vein Medical, Inc. Company Overview 220

5.57.1 Deep Vein Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220

5.58 Dextera Surgical Inc Company Overview 221

5.58.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 221

5.59 Dingke Medical Technology (Suzhou) Co Ltd Company Overview 222

5.59.1 Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 222

5.60 Dongguan TT Medical Inc Company Overview 223

5.60.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.61 Dublin City University Company Overview 226

5.61.1 Dublin City University Pipeline Products & Ongoing Clinical Trials Overview 226

5.62 Echopoint Medical Ltd Company Overview 227

5.62.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 227

5.63 Edwards Lifesciences Corp Company Overview 229

5.63.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 229

5.64 Efemoral Medical LLC Company Overview 230

5.64.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 230

5.65 Efferent Labs Inc Company Overview 234

5.65.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 234

5.66 Electroformed Stents Inc Company Overview 235

5.66.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 235

5.67 Elixir Medical Corp Company Overview 238

5.67.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 238

5.68 Emboline, Inc. Company Overview 239

5.68.1 Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 239

5.69 Endocor GmbH Company Overview 242

5.69.1 Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 242

5.70 Endomimetics LLC Company Overview 243

5.70.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 243

5.71 EndoPhlebex Technologies, Inc Company Overview 244

5.71.1 EndoPhlebex Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 244

5.72 enVVeno Medical Corp Company Overview 245

5.72.1 enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 245

5.73 EpiEP, Inc. Company Overview 250

5.73.1 EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 250

5.74 Eqalix, Inc. Company Overview 251

5.74.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 251

5.75 eucatech AG Company Overview 252

5.75.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 252

5.76 Ev3 Inc Company Overview 253

5.76.1 Ev3 Inc Pipeline Products & Ongoing Clinical Trials Overview 253

5.77 Evasc Medical Systems Corp Company Overview 254

5.77.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 254

5.78 Eximo Medical Ltd Company Overview 255

5.78.1 Eximo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 255

5.79 Filterlex Medical Ltd Company Overview 256

5.79.1 Filterlex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 256

5.80 FIT Biotech Oy (Inactive) Company Overview 257

5.80.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 257

5.81 Flomatrix Pty Ltd Company Overview 259

5.81.1 Flomatrix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5.82 FlowCo Inc. Company Overview 260

5.82.1 FlowCo Inc. Pipeline Products & Ongoing Clinical Trials Overview 260

5.83 Fluidx Medical Technology LLC Company Overview 261

5.83.1 Fluidx Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 261

5.84 Genesis MedTech International Pvt Ltd Company Overview 262

5.84.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 262

5.85 George Washington University Company Overview 265

5.85.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 265

5.86 Gradient Denervation Technologies Company Overview 266

5.86.1 Gradient Denervation Technologies Pipeline Products & Ongoing Clinical Trials Overview 266

5.87 Guerbet SA Company Overview 270

5.87.1 Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview 270

5.88 Hadassah Medical Center Company Overview 273

5.88.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 273

5.89 Handok-Kalos Medical Company Overview 274

5.89.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview 274

5.90 Hansen Medical Inc (Inactive) Company Overview 277

5.90.1 Hansen Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 277

5.91 Harvard University Company Overview 278

5.91.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 278

5.92 HeMo Bioengineering Ltd Company Overview 279

5.92.1 HeMo Bioengineering Ltd Pipeline Products & Ongoing Clinical Trials Overview 279

5.93 Hexacath SA Company Overview 283

5.93.1 Hexacath SA Pipeline Products & Ongoing Clinical Trials Overview 283

5.94 ID Nest Medical SAS Company Overview 284

5.94.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 284

5.95 Inari Medical Inc Company Overview 285

5.95.1 Inari Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 285

5.96 InnoRa GmbH Company Overview 286

5.96.1 InnoRa GmbH Pipeline Products & Ongoing Clinical Trials Overview 286

5.97 Innova Vascular Inc Company Overview 287

5.97.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 287

5.98 Innovative Cardiovascular Solutions, LLC Company Overview 289

5.98.1 Innovative Cardiovascular Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 289

5.99 Innovein Medical Inc Company Overview 292

5.99.1 Innovein Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 292

5.100 Innovia LLC Company Overview 295

5.100.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 295

5.101 InspireMD Inc Company Overview 297

5.101.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview 297

5.102 Instylla Inc Company Overview 304

5.102.1 Instylla Inc Pipeline Products & Ongoing Clinical Trials Overview 304

5.103 International Cardio Corp Company Overview 307

5.103.1 International Cardio Corp Pipeline Products & Ongoing Clinical Trials Overview 307

5.104 InterVene Inc. Company Overview 310

5.104.1 InterVene Inc. Pipeline Products & Ongoing Clinical Trials Overview 310

5.105 Intressa Vascular SA Company Overview 313

5.105.1 Intressa Vascular SA Pipeline Products & Ongoing Clinical Trials Overview 313

5.106 InVera Medical Ltd Company Overview 314

5.106.1 InVera Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 314

5.107 IPI Singapore Company Overview 315

5.107.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 315

5.108 Javelin Medical Ltd Company Overview 316

5.108.1 Javelin Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 316

5.109 Johns Hopkins University Company Overview 319

5.109.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 319

5.110 Keystone Heart Ltd Company Overview 320

5.110.1 Keystone Heart Ltd Pipeline Products & Ongoing Clinical Trials Overview 320

5.111 Kona Medical Inc Company Overview 321

5.111.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 321

5.112 Kyoto Medical Planning Co Ltd Company Overview 322

5.112.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 322

5.113 LeMaitre Vascular Inc Company Overview 324

5.113.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 324

5.114 LeoMed, LLC Company Overview 326

5.114.1 LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview 326

5.115 Lepu Medical Technology (Beijing) Co Ltd Company Overview 327

5.115.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 327

5.116 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview 330

5.116.1 Lepu Scientech Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 330

5.117 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 331

5.117.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 331

5.118 LimFlow SA Company Overview 335

5.118.1 LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview 335

5.119 LuSeed Vascular Company Overview 339

5.119.1 LuSeed Vascular Pipeline Products & Ongoing Clinical Trials Overview 339

5.120 Lutonix Inc Company Overview 340

5.120.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview 340

5.121 Lyra Therapeutics Inc Company Overview 341

5.121.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 341

5.122 Marblehead Medical LLC Company Overview 343

5.122.1 Marblehead Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 343

5.123 Mayo Clinic Company Overview 344

5.123.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 344

5.124 Medical Device Creations Ltd. Company Overview 345

5.124.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 345

5.125 Medikit Co Ltd Company Overview 346

5.125.1 Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 346

5.126 Medtronic Plc Company Overview 347

5.126.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 347

5.127 Mercator MedSystems Inc Company Overview 355

5.127.1 Mercator MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 355

5.128 Meril Life Sciences Pvt Ltd Company Overview 358

5.128.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 358

5.129 Micell Technologies Inc Company Overview 363

5.129.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 363

5.130 Micro Medical Solutions Inc Company Overview 365

5.130.1 Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 365

5.131 MicroPort CardioFlow Medtech Corp Company Overview 368

5.131.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview 368

5.132 MicroPort Scientific Corp Company Overview 369

5.132.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 369

5.133 MIV Therapeutics Inc Company Overview 374

5.133.1 MIV Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 374

5.134 Nanjing SealMed Medical Technology Corp Ltd Company Overview 375

5.134.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview 375

5.135 Nanjing Xinke Medical Devices Co Ltd Company Overview 376

5.135.1 Nanjing Xinke Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 376

5.136 Natec Medical Ltd Company Overview 377

5.136.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 377

5.137 Navi Medical Technologies Pty Ltd Company Overview 378

5.137.1 Navi Medical Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 378

5.138 Navis Medical Company Overview 381

5.138.1 Navis Medical Pipeline Products & Ongoing Clinical Trials Overview 381

5.139 Neovasc Inc Company Overview 382

5.139.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 382

5.140 Nesstent Ltd. Company Overview 383

5.140.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 383

5.141 Neurosonix Ltd. Company Overview 384

5.141.1 Neurosonix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 384

5.142 NewMed Medical Co Ltd Company Overview 385

5.142.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 385

5.143 NIH Office of Technology Transfer Company Overview 387

5.143.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 387

5.144 Nipro Corp Company Overview 388

5.144.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 388

5.145 Northwestern University Company Overview 389

5.145.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 389

5.146 Northwind Medical Inc Company Overview 390

5.146.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 390

5.147 NovaPulse Ltd Company Overview 391

5.147.1 NovaPulse Ltd Pipeline Products & Ongoing Clinical Trials Overview 391

5.148 Novoheart Holdings Inc Company Overview 392

5.148.1 Novoheart Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 392

5.149 NSVascular, Inc. Company Overview 393

5.149.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 393

5.150 NuVascular Technologies Inc Company Overview 394

5.150.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 394

5.151 OrbusNeich Company Overview 395

5.151.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview 395

5.152 Orchestra BioMed Inc Company Overview 400

5.152.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 400

5.153 Oregon Health & Science University Company Overview 401

5.153.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 401

5.154 Palmaz Scientific Inc (Inactive) Company Overview 403

5.154.1 Palmaz Scientific Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 403

5.155 PerAssist Ltd Company Overview 404

5.155.1 PerAssist Ltd Pipeline Products & Ongoing Clinical Trials Overview 404

5.156 PeriTec Biosciences Ltd Company Overview 405

5.156.1 PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 405

5.157 Perseus Biomed Ltd Company Overview 407

5.157.1 Perseus Biomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 407

5.158 PQ Bypass Inc Company Overview 408

5.158.1 PQ Bypass Inc Pipeline Products & Ongoing Clinical Trials Overview 408

5.159 Praxis Medical Devices Ltd Company Overview 410

5.159.1 Praxis Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 410

5.160 ProMed Inc Company Overview 413

5.160.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview 413

5.161 Protembis GmbH Company Overview 414

5.161.1 Protembis GmbH Pipeline Products & Ongoing Clinical Trials Overview 414

5.162 Pulsus Medical LLC (Inactive) Company Overview 417

5.162.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 417

5.163 QT Vascular Ltd Company Overview 418

5.163.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 418

5.164 QualiMed Innovative Medizinprodukte GmbH Company Overview 419

5.164.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 419

5.165 Qvanteq AG Company Overview 422

5.165.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview 422

5.166 R3 Vascular Inc Company Overview 423

5.166.1 R3 Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 423

5.167 RadSense Company Overview 426

5.167.1 RadSense Pipeline Products & Ongoing Clinical Trials Overview 426

5.168 Reflow Medical, Inc. Company Overview 427

5.168.1 Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 427

5.169 RegenMedTX LLC Company Overview 431

5.169.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 431

5.170 Renal Dynamics, LLC Company Overview 432

5.170.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 432

5.171 Renaly Ltd Company Overview 433

5.171.1 Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview 433

5.172 Reprieve Cardiovascular Inc Company Overview 434

5.172.1 Reprieve Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 434

5.173 REVA Medical Inc Company Overview 437

5.173.1 REVA Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 437

5.174 Rex Medical LP Company Overview 440

5.174.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 440

5.175 Rontis AG Company Overview 442

5.175.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 442

5.176 Rutgers The State University of New Jersey Company Overview 443

5.176.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 443

5.177 Shanghai AngioCare Medical Technology Co Ltd Company Overview 444

5.177.1 Shanghai AngioCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 444

5.178 Shanghai Bio-heart Biological Technology Co Ltd Company Overview 446

5.178.1 Shanghai Bio-heart Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 446

5.179 Shanghai Changde Medical Technology Co Ltd Company Overview 448

5.179.1 Shanghai Changde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 448

5.180 Shanghai Golden Leaf Medtech Co Ltd Company Overview 456

5.180.1 Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 456

5.181 Shanghai Healing Medical Instruments Co Ltd Company Overview 457

5.181.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 457

5.182 Shanghai HeartCare Medical Technology Co Ltd Company Overview 458

5.182.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 458

5.183 Shanghai MicroPort Endovascular MedTech Group Co Ltd Company Overview 459

5.183.1 Shanghai MicroPort Endovascular MedTech Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 459

5.184 Shanghai Shenqi Medical Technology Co Ltd Company Overview 464

5.184.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 464

5.185 Shanghai Xuanyu Medical Equipment Co Ltd Company Overview 465

5.185.1 Shanghai Xuanyu Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 465

5.186 Shape Memory Medical Inc Company Overview 466

5.186.1 Shape Memory Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 466

5.187 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview 469

5.187.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 469

5.188 Shockwave Medical Inc Company Overview 477

5.188.1 Shockwave Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 477

5.189 SiL Vascular Ltd Company Overview 480

5.189.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 480

5.190 SoniVie Ltd. Company Overview 481

5.190.1 SoniVie Ltd. Pipeline Products & Ongoing Clinical Trials Overview 481

5.191 SonoVascular Inc Company Overview 484

5.191.1 SonoVascular Inc Pipeline Products & Ongoing Clinical Trials Overview 484

5.192 Sound Interventions, Inc. Company Overview 485

5.192.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 485

5.193 SoundBite Medical Solutions Inc Company Overview 486

5.193.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 486

5.194 Spectranetics Corp Company Overview 490

5.194.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 490

5.195 SpectroCon LLC Company Overview 491

5.195.1 SpectroCon LLC Pipeline Products & Ongoing Clinical Trials Overview 491

5.196 Spectrumedics Medical Technology (Shanghai) Co Ltd Company Overview 492

5.196.1 Spectrumedics Medical Technology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 492

5.197 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 493

5.197.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 493

5.198 St. Jude Medical LLC Company Overview 494

5.198.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 494

5.199 Stanford University Company Overview 495

5.199.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 495

5.200 Stemplant LLC Company Overview 498

5.200.1 Stemplant LLC Pipeline Products & Ongoing Clinical Trials Overview 498

5.201 Straub Medical AG Company Overview 499

5.201.1 Straub Medical AG Pipeline Products & Ongoing Clinical Trials Overview 499

5.202 SurModics Inc Company Overview 502

5.202.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview 502

5.203 Suzhou Rainmed Medical Technology Co Ltd Company Overview 510

5.203.1 Suzhou Rainmed Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 510

5.204 Suzhou Xinmai Medical Equipment Co Ltd Company Overview 511

5.204.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 511

5.205 Suzhou Yinluo Medical Devices Co Ltd Company Overview 515

5.205.1 Suzhou Yinluo Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 515

5.206 Suzhou Zhonghui Medical Technology Co Ltd Company Overview 516

5.206.1 Suzhou Zhonghui Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 516

5.207 Symple Surgical Inc Company Overview 519

5.207.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 519

5.208 Synergy Flow Ltd Company Overview 520

5.208.1 Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview 520

5.209 Tailored Medical Devices Inc Company Overview 521

5.209.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 521

5.210 Tel Aviv University Company Overview 522

5.210.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 522

5.211 Teleflex Inc Company Overview 523

5.211.1 Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 523

5.212 Tepha Inc Company Overview 525

5.212.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview 525

5.213 Terumo Corp Company Overview 526

5.213.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 526

5.214 Terumo Interventional Systems Company Overview 529

5.214.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 529

5.215 Thrombx Medical Inc Company Overview 531

5.215.1 Thrombx Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 531

5.216 TissueGen Inc Company Overview 534

5.216.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview 534

5.217 Tractivus SL Company Overview 535

5.217.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 535

5.218 Transit Scientific LLC Company Overview 536

5.218.1 Transit Scientific LLC Pipeline Products & Ongoing Clinical Trials Overview 536

5.219 TransMed7 LLC Company Overview 539

5.219.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview 539

5.220 Trinity College Dublin Company Overview 540

5.220.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 540

5.221 TripleMed BV Company Overview 541

5.221.1 TripleMed BV Pipeline Products & Ongoing Clinical Trials Overview 541

5.222 Ts3 Medical, Inc. Company Overview 544

5.222.1 Ts3 Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 544

5.223 University of Colorado Company Overview 546

5.223.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 546

5.224 University of Illinois at Chicago Company Overview 547

5.224.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 547

5.225 University of Louisville Company Overview 548

5.225.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 548

5.226 University of Michigan Company Overview 549

5.226.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 549

5.227 University of Minnesota Company Overview 550

5.227.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 550

5.228 University of Montana Company Overview 553

5.228.1 University of Montana Pipeline Products & Ongoing Clinical Trials Overview 553

5.229 University of Nebraska Company Overview 554

5.229.1 University of Nebraska Pipeline Products & Ongoing Clinical Trials Overview 554

5.230 University of New Mexico Company Overview 555

5.230.1 University of New Mexico Pipeline Products & Ongoing Clinical Trials Overview 555

5.231 University of Pittsburgh Company Overview 556

5.231.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 556

5.232 University of Pittsburgh Medical Center Company Overview 559

5.232.1 University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 559

5.233 University of Rochester Company Overview 560

5.233.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 560

5.234 University of Sydney Company Overvi

Table

Peripheral Vascular Devices – Pipeline Products by Stage of Development 49

Peripheral Vascular Devices – Pipeline Products by Segment 50

Peripheral Vascular Devices – Pipeline Products by Territory 52

Peripheral Vascular Devices – Pipeline Products by Regulatory Path 54

Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date 56

Peripheral Vascular Devices – Ongoing Clinical Trials 57

Peripheral Vascular Devices Companies – Pipeline Products by Stage of Development 58

Peripheral Vascular Devices – Pipeline Products by Stage of Development 68

3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 79

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Status 79

Bioresorbable Drug Eluting Peripheral Polymer Stent – Product Description 79

Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Chemical RDN System – Product Status 80

Chemical RDN System – Product Description 80

Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) – Product Status 80

Emboshield Pro Rapid Exchange Embolic Protection System (Generation 5) – Product Description 81

ESPRIT Bioresorbable Vascular Scaffold – Product Status 81

ESPRIT Bioresorbable Vascular Scaffold – Product Description 81

ESPRIT BTK Bioresorbable Vascular Scaffold – Product Status 82

ESPRIT BTK Bioresorbable Vascular Scaffold – Product Description 82

Next Generation SUPERA Delivery System – Product Status 82

Next Generation SUPERA Delivery System – Product Description 83

Abbott Vascular Inc – Ongoing Clinical Trials Overview 84

ESPRIT BTK Bioresorbable Vascular Scaffold – LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-below the Knee) Randomized Controlled Trial 85

ESPRIT BTK Bioresorbable Vascular Scaffold – LIFE-BTK Pharmacokinetics (PK) Sub-study 85

Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 86

Peregrine System Kit – Hypertension – Product Status 86

Peregrine System Kit – Hypertension – Product Description 86

Ablative Solutions Inc – Ongoing Clinical Trials Overview 87

Peregrine System Kit – Hypertension – A Phase II, Multicenter, Blinded, Sham Procedure-controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, in the Absence of Antihypertensive Medications 88

Peregrine System Kit – Hypertension – A Pivotal, Multicenter, Blinded, Sham procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension 88

Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

AcoArt-Litos Drug-Eluting Balloon – Product Status 89

AcoArt-Litos Drug-Eluting Balloon – Product Description 89

AcoArt-Tulip – Product Status 89

AcoArt-Tulip – Product Description 90

Peripheral IVL System – Product Status 90

Peripheral IVL System – Product Description 90

Acotec Scientific Co Ltd – Ongoing Clinical Trials Overview 92

AcoArt-Litos Drug-Eluting Balloon – A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery 93

AcoArt-Litos Drug-Eluting Balloon – All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment 93

AcoArt-Litos Drug-Eluting Balloon – Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia 93

AcoArt-Tulip – A Post Market Clinical Study to Evaluate the Safety and Efficacy of the Acotec Drug-coated Balloon in the Treatment of the Below-the-knee Artery 94

AcoArt-Tulip – All Comers Post Market Clinical Follow-up to Continue the Surveillance of the Acotec Drug Coated PTA Catheter Orchid, Tulip and Litos in Lower Limb Treatment 94

Acotec Scientific Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

Below-The-Knee PTA Balloon – Product Status 95

Below-The-Knee PTA Balloon – Product Description 95

Carotid Stent – Product Status 96

Carotid Stent – Product Description 96

Peripheral Coil – Product Status 96

Peripheral Coil – Product Description 96

Peripheral Scoring Balloon – Product Status 97

Peripheral Scoring Balloon – Product Description 97

Peripheral Spot Stent – Product Status 97

Peripheral Spot Stent – Product Description 98

Peripheral Triple-Guidewire Balloon – Product Status 98

Peripheral Triple-Guidewire Balloon – Product Description 98

Spot Stent System – Product Status 99

Spot Stent System – Product Description 99

Acotec Scientific Holdings Ltd – Ongoing Clinical Trials Overview 100

Spot Stent System – A Prospective, Multicenter and Randomized Controlled Trial to Evaluate the Efficacy and Safety of a Spot Stent System Using in the Percutaneous Transluminal Angioplasty of Femoropopliteal Arteries 101

Adept Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 102

Venous Stripping Device – Product Status 102

Venous Stripping Device – Product Description 102

Agile Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Angler Peripheral Microcatheter – Product Status 103

Angler Peripheral Microcatheter – Product Description 103

Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 104

Peripheral Access Device – Peripheral Vascular Disease – Product Status 104

Peripheral Access Device – Peripheral Vascular Disease – Product Description 104

Alucent Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 105

Natural Vascular Scaffolding Device – Below-The-Knee – Product Status 105

Natural Vascular Scaffolding Device – Below-The-Knee – Product Description 105

Alucent Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Natural Vascular Scaffolding Device – Product Status 106

Natural Vascular Scaffolding Device – Product Description 106

Alucent Biomedical Inc – Ongoing Clinical Trials Overview 107

Natural Vascular Scaffolding Device – A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF 108

Natural Vascular Scaffolding Device – Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I 108

Natural Vascular Scaffolding Device – Study to Evaluate the Safety and Efficacy of the Alucent Natural Vascular Scaffolding (Alucentnvs) Vessel Restoration System with Photoactivated Linking in the Treatment of Peripheral Artery Disease (PAD) of the Lower Extremities 108

amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 110

UNITY-B Peripheral Stent – Product Status 110

UNITY-B Peripheral Stent – Product Description 110

Amplitude Vascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 111

Pulsatile Intravascular Lithotripsy System – Peripheral Artery Diseases – Product Status 111

Pulsatile Intravascular Lithotripsy System – Peripheral Artery Diseases – Product Description 111

Pulse Intravascular Lithotripsy System – Peripheral Arterial Disease – Product Status 111

Pulse Intravascular Lithotripsy System – Peripheral Arterial Disease – Product Description 112

Amplitude Vascular Systems Inc – Ongoing Clinical Trials Overview 113

Pulse Intravascular Lithotripsy System – Peripheral Arterial Disease – A Prospective, Single-Arm, Multicenter, Feasibility Study to Evaluate Safety and Performance of the Amplitude Vascular System (AVS) Pulse Peripheral Intravascular Lithotripsy (IVL) for Treating Subjects With Calcific Femoropopliteal Arteries in Conjunction With Adjunctive Therapy 114

Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 115

Adrion MRI Guidewire – Product Status 115

Adrion MRI Guidewire – Product Description 115

Zero-Profile PTA Balloon – Product Status 115

Zero-Profile PTA Balloon – Product Description 116

AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview 117

Pillar Bifurcation Reconstruction Device – Product Status 117

Pillar Bifurcation Reconstruction Device – Product Description 117

AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview 118

NF-kB Decoy Oligo Coated PTA Balloon Catheter – Product Status 118

NF-kB Decoy Oligo Coated PTA Balloon Catheter – Product Description 118

AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 119

AngioCure TOP-C Smart Balloon Catheter – Product Status 119

AngioCure TOP-C Smart Balloon Catheter – Product Description 119

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Automated Fluid Management System – Product Status 120

Automated Fluid Management System – Product Description 120

Inflation Device – Product Status 120

Inflation Device – Product Description 121

Peripheral Vascular Drainage Line Extension – Product Status 121

Peripheral Vascular Drainage Line Extension – Product Description 121

AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview 122

EMBRACE – Product Status 122

EMBRACE – Product Description 122

AorticLab Sarl – Ongoing Clinical Trials Overview 123

EMBRACE – Clinical Study of a Novel Transcatheter Anti-embolic Filter (TAF) for Cerebral Protection During Aortic Valve Interventions 124

Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 125

Femoral Artery Closure Device – Product Status 125

Femoral Artery Closure Device – Product Description 125

APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 126

0.018″ PTA Balloon Dilatation Catheter – Product Status 126

0.018″ PTA Balloon Dilatation Catheter – Product Description 126

0.035″ PTA Balloon Dilatation Catheter – Product Status 127

0.035″ PTA Balloon Dilatation Catheter – Product Description 127

Distal Embolic Protection System – Product Status 127

Distal Embolic Protection System – Product Description 127

SPG Guidewire – Product Status 128

SPG Guidewire – Product Description 128

Thrombolytic Catheter – Product Status 128

Thrombolytic Catheter – Product Description 128

Transjugular Intrahepatic Puncture System – Product Status 129

Transjugular Intrahepatic Puncture System – Product Description 129

APT Medical Inc – Ongoing Clinical Trials Overview 130

Transjugular Intrahepatic Puncture System – A Prospective Multicenter, Single-Arm Clinical Trial to Evaluate the Efficacy of a Covered Stent To Treat Portal Hypertension Complications in the TIPS (Transjugular Intrahepatic Portosystemic Shunt) 131

Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Bioresorbable Stent – Peripheral Vascular Disease – Product Status 132

Bioresorbable Stent – Peripheral Vascular Disease – Product Description 132

Artio Medical Pipeline Products & Ongoing Clinical Trials Overview 133

Aneura Embolization Device – Product Status 133

Aneura Embolization Device – Product Description 133

Aneura Embolization Coil – Product Status 134

Aneura Embolization Coil – Product Description 134

Blockstent Microcatheter – Product Status 134

Blockstent Microcatheter – Product Description 134

Solus Flex Embolization Device – Product Status 135

Solus Flex Embolization Device – Product Description 135

Artventive Medical Group Inc Pipeline Products & Ongoing Clinical Trials Overview 136

ArtVentive EOS Device – Product Status 136

ArtVentive EOS Device – Product Description 136

Artventive EOS Gen II – Product Status 137

Artventive EOS Gen II – Product Description 137

ArtVentive EOS Peripheral Device – 18mm – Product Status 137

ArtVentive EOS Peripheral Device – 18mm – Product Description 138

ArtVentive EOS Peripheral Device – 8mm – Product Status 138

ArtVentive EOS Peripheral Device – 8mm – Product Description 138

EOS – 5F Guide Catheter – Product Status 138

EOS – 5F Guide Catheter – Product Description 139

Ascenion GmbH Pipeline Products & Ongoing Clinical Trials Overview 140

Paclitaxel-Coated Balloon Catheter – Product Status 140

Paclitaxel-Coated Balloon Catheter – Product Description 140

Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 141

Low Profile Thrombus Extraction Catheter – Product Status 141

Low Profile Thrombus Extraction Catheter – Product Description 141

Avalon Laboratories LLC Pipeline Products & Ongoing Clinical Trials Overview 142

Avalon Elite SLC Arterial – Product Status 142

Avalon Elite SLC Arterial – Product Description 142

Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview 143

Peripheral Embolization Device – Product Status 143

Peripheral Embolization Device – Product Description 143

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 144

BD Liverty TIPS Stent Graft – Product Status 144

BD Liverty TIPS Stent Graft – Product Description 144

BD Sirolimus Drug Coated Balloon Catheter – Product Status 145

BD Sirolimus Drug Coated Balloon Catheter – Product Description 145

Becton Dickinson and Co – Ongoing Clinical Trials Overview 146

BD Sirolimus Drug Coated Balloon Catheter – A Prospective, Multicenter, Single Arm, Non-Randomized, Study to Assess the Performance and Safety of BD Sirolimus Drug Coated Balloon Catheter for Treatment of Femoropopliteal Arteries 147

BD Liverty TIPS Stent Graft – A Global, Prospective, Multi-center, Single-arm Clinical Study for the Treatment of Complications from Portal Hypertension, Assessing the Safety and Effectiveness of the Investigational BD Liverty TIPS Stent Graft 148

Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 149

Clot Retrieval Electrode Catheter – Product Status 149

Clot Retrieval Electrode Catheter – Product Description 149

Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 150

Oscar Peripheral Multifunctional Catheter System – Product Status 150

Oscar Peripheral Multifunctional Catheter System – Product Description 150

Biotyx Medical (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

IBS Titan – Product Status 151

IBS Titan – Product Description 151

Biotyx Medical (Shenzhen) Co Ltd – Ongoing Clinical Trials Overview 152

IBS Titan – A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL 153

IBS Titan – A Prospective, Multicentre, Single Arm Clinical Trial to Assess the Safety and Effectiveness of Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan) in Treating Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease 153

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 154

Critical Limb Ischemia Catheter – Product Status 154

Critical Limb Ischemia Catheter – Product Description 154

Drug Coated Balloon – Below-The-Knee (BTK) – Product Status 155

Drug Coated Balloon – Below-The-Knee (BTK) – Product Description 155

High Pressure Balloon – Venous Disease – Product Status 155

High Pressure Balloon – Venous Disease – Product Description 155

Interventional Oncology Embolic Coil – Product Status 156

Interventional Oncology Embolic Coil – Product Description 156

Next Generation 0.018” Balloon – Product Status 156

Next Generation 0.018” Balloon – Product Description 157

Ranger Paclitaxel-Coated PTA Balloon Catheter – Product Status 157

Ranger Paclitaxel-Coated PTA Balloon Catheter – Product Description 157

SAVAL Drug Eluting Stent BTK – Product Status 158

SAVAL Drug Eluting Stent BTK – Product Description 158

Symbiot Covered Stent System – Product Status 158

Symbiot Covered Stent System – Product Description 158

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Status 159

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Product Description 159

Boston Scientific Corp – Ongoing Clinical Trials Overview 160

Ranger Paclitaxel-Coated PTA Balloon Catheter – A Prospective, Single-Centre Study Investigating the Clinical Use and Safety of the Jetstream Atherectomy With Drug Coated Balloon (Ranger) for the Treatment of Dysfunctional Arterio-Venous Graft Stenosis 161

Ranger Paclitaxel-Coated PTA Balloon Catheter – Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease (ARTEMIS Trial) 161

Ranger Paclitaxel-Coated PTA Balloon Catheter – Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE) 161

Ranger Paclitaxel-Coated PTA Balloon Catheter – Efficacy of Rotational Atherectomy System Associated with Drug Coated Balloon Angioplasty (with or without Stent Placement) in the Management of Lower Limb Ischemia (ELLIPSE): “Real Life” Observational Study 161

Ranger Paclitaxel-Coated PTA Balloon Catheter – Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm) 162

Ranger Paclitaxel-Coated PTA Balloon Catheter – Ranger Drug-coated Balloon Catheters Post Market Surveillance 162

Ranger Paclitaxel-Coated PTA Balloon Catheter – RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA) 162

Wallstent RP Endoprosthesis – Venous Outflow Obstruction – Sinai Vein Stent Registry 164

SAVAL Drug Eluting Stent BTK – A Randomized Trial Comparing the Drug-eluting Stent (DES) Below-the-knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) Versus Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia 165

Boston Scientific Scimed Inc Pipeline Products & Ongoing Clinical Trials Overview 169

Pulsivity – Product Status 169

Pulsivity – Product Description 169

Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview 170

Viper Limb Ischemia – Product Status 170

Viper Limb Ischemia – Product Description 170

Brattea Pipeline Products & Ongoing Clinical Trials Overview 171

6-Electrode Ablation Catheter – Product Status 171

6-Electrode Ablation Catheter – Product Description 171

CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 172

EpiClose Plus – Product Status 172

EpiClose Plus – Product Description 172

Cardio-Flow Ltd. Pipeline Products & Ongoing Clinical Trials Overview 173

EmboPRO EPD – Product Status 173

EmboPRO EPD – Product Description 173

Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 174

LEGFLOW OTW – Product Status 174

LEGFLOW OTW – Product Description 174

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 175

Chronic Total Occlusion Catheter – Product Status 175

Chronic Total Occlusion Catheter – Product Description 175

Next Gen Guide Wire – Product Status 176

Next Gen Guide Wire – Product Description 176

PAD Radial Guidewire – Product Status 176

PAD Radial Guidewire – Product Description 176

Peripheral PTA Balloon Catheter – Product Status 177

Peripheral PTA Balloon Catheter – Product Description 177

WIRION EPD System – LE Atherectomy – Product Status 177

WIRION EPD System – LE Atherectomy – Product Description 177

Cardiva Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 179

VASCADE MVP System – Product Status 179

VASCADE MVP System – Product Description 179

Cardiva Medical Inc – Ongoing Clinical Trials Overview 180

VASCADE MVP System – A Multi-center, Prospective, Single Arm Registry to Evaluate Procedural Outcomes Using the Cardiva VASCADE MVP VVCS Closure Device after Catheter-based Atrial Fibrillation Interventions for Patients Who Are Discharged the Same Day 181

Catharos Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 182

Sentinel Catheter – Product Status 182

Sentinel Catheter – Product Description 182

CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 183

CaveoVasc XL – Product Status 183

CaveoVasc XL – Product Description 183

CaveoVenous – Product Status 183

CaveoVenous – Product Description 184

Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 185

Peripheral Everolimus Drug-Coated Balloon – Product Status 185

Peripheral Everolimus Drug-Coated Balloon – Product Description 185

Chansu Vascular Technologies LLC – Ongoing Clinical Trials Overview 186

Peripheral Everolimus Drug-Coated Balloon – A First in-human Study Evaluating the Efficacy of Peripheral Everolimus Drug-coated Balloon in Patients with Peripheral Artery Disease: CVT-SFA 187

Peripheral Everolimus Drug-Coated Balloon – Chansu Vascular Technologies Everolimus-Coated Balloon Percutaneous Transluminal Angioplasty Catheter First-in-Human Clinical Investigation 187

Clemson University Pipeline Products & Ongoing Clinical Trials Overview 188

Porous Elastin – Derived Vascular Graft – Product Status 188

Porous Elastin – Derived Vascular Graft – Product Description 188

CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 189

CloSys HD – Product Status 189

CloSys HD – Product Description 189

Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 190

MagicTouch PTA Balloon Catheter – Product Status 190

MagicTouch PTA Balloon Catheter – Product Description 190

Concept Medical Inc – Ongoing Clinical Trials Overview 192

MagicTouch PTA Balloon Catheter – Comparison of Sirolimus Vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia 193

MagicTouch PTA Balloon Catheter – Head-to-Head Comparison of Sirolimus Versus Paclitaxel Drug-Eluting Balloon Angioplasty in the Femoropopliteal Artery 193

MagicTouch PTA Balloon Catheter – Major Adverse Limb Events in Patients with Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated with Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty 193

MagicTouch PTA Balloon Catheter – Randomized Controlled Trial of First SirolimUs Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Below the Knee Arterial Disease: FUTURE BTK 193

MagicTouch PTA Balloon Catheter – Randomized Controlled Trial of First Sirolimus Coated Balloon Versus Standard Balloon Angioplasty in the Treatment of Superficial Femoral Artery and Popliteal Artery Disease 194

Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 195

Neuroguard IEP System – Product Status 195

Neuroguard IEP System – Product Description 195

Superficial Femoral Artery Balloon – Product Status 196

Superficial Femoral Artery Balloon – Product Description 196

Tibial Artery Drug Eluting Balloon – Product Status 196

Tibial Artery Drug Eluting Balloon – Product Description 196

Contego Medical LLC – Ongoing Clinical Trials Overview 198

Neuroguard IEP System – Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1 Delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter and a Novel Carotid Stent II 199

Neuroguard IEP System – Protection Against Emboli During caRotid Artery Stenting Using a Neuroguard IEP® Direct 3-in-1 Delivery System Comprised oF a pOst-dilation Balloon, integRated eMbolic Filter, and A Novel Carotid stEnt – the PERFORMANCE III Study 199

Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 200

Drug-Eluting Stent – Below The Knee – Product Status 200

Drug-Eluting Stent – Below The Knee – Product Description 200

Zenith Connection Endovascular Covered Stent – Product Status 201

Zenith Connection Endovascular Covered Stent – Product Description 201

Cook Medical Inc – Ongoing Clinical Trials Overview 202

Zenith Connection Endovascular Covered Stent – The Enzen Trial: Comparison of EVAR Outcomes With Endurant Versus Zenith Endoprosthesis: a Prospective Analysis. 203

Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 204

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Status 204

FlexStent Self Expanding Below-The-Knee Venous Stent System – Product Description 204

FlexStent Self Expanding Venous Stent System – Product Status 205

FlexStent Self Expanding Venous Stent System – Product Description 205

Radianz Radial Peripheral System – Product Status 205

Radianz Radial Peripheral System – Product Description 205

S.M.A.R.T. RADIANZ Vascular Stent System – Product Status 206

S.M.A.R.T. RADIANZ Vascular Stent System – Product Description 206

SELUTION SLR 018 DEB – Peripheral Artery Disease – Product Status 206

SELUTION SLR 018 DEB – Peripheral Artery Disease – Product Description 206

Tibial SE FlexStent – Product Status 207

Tibial SE FlexStent – Product Description 207

Cordis Corp – Ongoing Clinical Trials Overview 208

SELUTION SLR 018 DEB – Peripheral Artery Disease – Intervention with Selution SLR Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial 209

SELUTION SLR 018 DEB – Peripheral Artery Disease – Pivotal Clinical Trial for the Treatment of Occlusive Disease of the Superficial Femoral Artery (SFA) Using SELUTION SLR Sirolimus-eluting Balloon 209

SELUTION SLR 018 DEB – Peripheral Artery Disease – Prospective Registry to Investigate the Safety and Efficacy of the Treatment with the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-inguinal Disease in Patients with Chronic Limb Threatening Ischemia from Singapore 209

SELUTION SLR 018 DEB – Peripheral Artery Disease – SAVE Trial – Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications 209

SELUTION SLR 018 DEB – Peripheral Artery Disease – Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation 210

SELUTION SLR 018 DEB – Peripheral Artery Disease – SELUTION SLR 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis 210

SELUTION SLR 018 DEB – Peripheral Artery Disease – SUCCESS (Selution, Safety, Efficacy, Health Economics and Proms) PTA Study 210

CorInnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 212

Hybrid Dynamic Stent – Product Status 212

Hybrid Dynamic Stent – Product Description 212

Covidien Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

NightHawk System – Product Status 213

NightHawk System – Product Description 213

CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 214

MedClose – Product Status 214

MedClose – Product Description 214

CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 215

VIVEXX Carotid Stent – Product Status 215

VIVEXX Carotid Stent – Product Description 215

CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview 216

Catheter Based Cryoablation System – Product Status 216

Catheter Based Cryoablation System – Product Description 216

CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview 217

Absorbaseal Vascular Closure Device – Product Status 217

Absorbaseal Vascular Closure Device – Product Description 217

Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 218

LifeJacket Stent Graft – Peripheral – Product Status 218

LifeJacket Stent Graft – Peripheral – Product Description 218

Deep Vein Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 219

Sail Valve – Product Status 219

Sail Valve – Product Description 219

Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 220

X-Port Vascular Access Closure Device – Product Status 220

X-Port Vascular Access Closure Device – Product Description 220

Dingke Medical Technology (Suzhou) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 221

Dissolve AV – Product Status 221

Dissolve AV – Product Description 221

Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Die Wire – Product Status 222

Die Wire – Product Description 222

Microcatheter – Product Status 222

Microcatheter – Product Description 223

Score PTA – Product Status 223

Score PTA – Product Description 223

Dublin City University Pipeline Products & Ongoing Clinical Trials Overview 224

Minimally Invasive Intravascular Device – Product Status 224

Minimally Invasive Intravascular Device – Product Description 224

Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

iKOs Guidewire – Peripheral Vascular Intervention – Product Status 225

iKOs Guidewire – Peripheral Vascular Intervention – Product Description 225

iKOs Microcatheter – Peripheral Vascular Intervention – Product Status 225

iKOs Microcatheter – Peripheral Vascular Intervention – Product Description 226

Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 227

EOS – Product Status 227

EOS – Product Description 227

Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 228

Efemoral Device – Product Status 228

Efemoral Device – Product Description 228

Efemoral Vascular Scaffold System (EVSS) – Product Status 228

Efemoral Vascular Scaffold System (EVSS) – Product Description 229

Efemoral Medical LLC – Ongoing Clinical Trials Overview 230

Efemoral Vascular Scaffold System (EVSS) – A Clinical Evaluation of the Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery 231

Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 232

RTI-LICD Plexisense – Product Status 232

RTI-LICD Plexisense – Product Description 232

Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview 233

ESI O-Cluder – Product Status 233

ESI O-Cluder – Product Description 233

Helical Stent – Product Status 234

Helical Stent – Product Description 234

Patch Stent – Product Status 234

Patch Stent – Product Description 234

Pleated Stent – Product Status 235

Pleated Stent – Product Description 235

Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 236

PRAVA Bioresorbable Scaffold – Product Status 236

PRAVA Bioresorbable Scaffold – Product Description 236

Emboline, Inc. Pipeline Products & Ongoing Clinical Trials Overview 237

Emboliner – Product Status 237

Emboliner – Product Description 237

Emboline, Inc. – Ongoing Clinical Trials Overview 238

Emboliner – Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device 239

Emboliner – Safety and Technical Performance Evaluation of the Emboliner Embolic Protection Device: A New Zealand Experience 239

Endocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 240

Endorenal – Product Status 240

Endorenal – Product Description 240

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 241

Peripheral Vascular Stent – Product Status 241

Peripheral Vascular Stent – Product Description 241

EndoPhlebex Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 242

Endovascular Venous Surgery Kit – Product Status 242

Endovascular Venous Surgery Kit – Product Description 242

enVVeno Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 243

enVVe – Product Status 243

enVVe – Product Description 243

VenoValve – Product Status 244

VenoValve – Product Description 244

enVVeno Medical Corp – Ongoing Clinical Trials Overview 245

VenoValve – First-in-human Study Evaluating the Efficacy of VenoValve Bioprosthetic Device in Treatment of Chronic Venous Insufficiency 246

VenoValve – The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) Study 246

enVVe – Transcatheter Anti-reflux, Venous Valve Endoprosthesis (TAVVE) First-in-Human Study 247

EpiEP, Inc. Pipeline Products & Ongoing Clinical Trials Overview 248

Femoral Artery Access Device – Product Status 248

Femoral Artery Access Device – Product Description 248

Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 249

Small Diameter Vascular Graft – Peripheral Artery Disease – Product Status 249

Small Diameter Vascular Graft – Peripheral Artery Disease – Product Description 249

eucatech AG Pipeline Products & Ongoing Clinical Trials Overview 250

Support – Product Status 250

Support – Product Description 250

Ev3 Inc Pipeline Products & Ongoing Clinical Trials Overview 251

RockHawk With SpiderFX Embolic Protection Device – Product Status 251

RockHawk With SpiderFX Embolic Protection Device – Product Description 251

Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials

Figures

Peripheral Vascular Devices – Pipeline Products by Stage of Development 51

Peripheral Vascular Devices – Pipeline Products by Segment 52

Peripheral Vascular Devices – Pipeline Products by Territory 54

Peripheral Vascular Devices – Pipeline Products by Regulatory Path 56

Peripheral Vascular Devices – Pipeline Products by Estimated Approval Date 57

Peripheral Vascular Devices – Ongoing Clinical Trials 58

Frequently asked questions

Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Peripheral Vascular Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.